# [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors

> **NCT00707343** · PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 15 (actual)

## Conditions studied

- Cancer
- Brain Tumors

## Interventions

- **RADIATION:** FLT-PET Imaging

## Key facts

- **NCT ID:** NCT00707343
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-31
- **Primary completion:** 2010-11-30
- **Final completion:** 2010-11-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00707343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00707343, "[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00707343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*